Researchers found that by December 2023, more than 1 in 3 of the medications being started for type 2 diabetes treatment were GLP-1RA-based medications.

Ozempic made our arms, bums and legs look like MELTED CANDLES': the terrifying new side effects rapidly emerging in young people taking weight-loss drugs Oxford Medical Products is planning on ...

As revenues fall in diabetes treatments, has the industry found a new revenue driver in weight-loss treatments ... as it progresses its drug candidate for obesity into mid-stage trials.

When it comes to managing weight loss and type 2 diabetes with medications, research shows that it's out with the old and in with the new.

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication years ago. Schumer, 43, praised the effects of Mounjaro (also known as ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

A U.S. senator said a GLP-1 drug changed his life — and now he's calling for widespread access to anti-obesity medications. In a New York Times ... approved for weight loss, chronic weight ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Novo Nordisk to Pay $2 Billion for New Weight Loss Drug TUESDAY, March 25, 2025 (HealthDay News) -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion ...

Of course, that is easier said than done, which is why drugs ... rapid weight loss (see “How they work”, below) also leads to notable declines in muscle mass. For instance, a 2021 study ...